Fig. 2.
Levels of human FVIII in NOD/SCID mouse plasma.
Blood was sampled on days 9, 28, 47, 97, and 156 after the administration of BOECs, and human FVIII was measured by ELISA. Results are shown for each mouse in the 4 groups that received eGFP-FVIII tBOECs. Cell dose is indicated per injection.